{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:41:02Z","timestamp":1789472462561,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency International Cooperative Research Project ATP Synthesis Regulation Project","doi-asserted-by":"publisher","award":["22H02503"],"award-info":[{"award-number":["22H02503"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007172","name":"National Agriculture and Food Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007173","name":"Bio-oriented Technology Research Advancement Institution","doi-asserted-by":"publisher","award":["16817557"],"award-info":[{"award-number":["16817557"]}],"id":[{"id":"10.13039\/501100007173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007173","name":"Bio-oriented Technology Research Advancement Institution","doi-asserted-by":"publisher","award":["JPJ008617.17935709"],"award-info":[{"award-number":["JPJ008617.17935709"]}],"id":[{"id":"10.13039\/501100007173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K15993"],"award-info":[{"award-number":["19K15993"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19KK0172"],"award-info":[{"award-number":["19KK0172"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15005"],"award-info":[{"award-number":["22K15005"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K19232"],"award-info":[{"award-number":["22K19232"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vetimm.2023.110609","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:56:37Z","timestamp":1683824197000},"page":"110609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Molecular characterization of immunoinhibitory factors PD-1\/PD-L1 in sheep"],"prefix":"10.1016","volume":"261","author":[{"given":"Wisa","family":"Tiyamanee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Konnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Okagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otgontuya","family":"Ganbaatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2023.110609_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.vetimm.2023.110609_bib2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/biology11091251","article-title":"The sheep as a large animal model for the investigation and treatment of human disorders","volume":"11","author":"Banstola","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.vetimm.2023.110609_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2023.110609_bib4","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1128\/IAI.73.9.5603-5611.2005","article-title":"Experimental infection model for Johne\u2019s disease in sheep","volume":"73","author":"Begg","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vetimm.2023.110609_bib5","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2023.110609_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus Docetaxel in advanced squamous-cell non\u2013small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.vetimm.2023.110609_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.vetimm.2023.110609_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","article-title":"PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2","volume":"32","author":"Carter","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vetimm.2023.110609_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/blood.V122.21.191.191","article-title":"Distinct roles of PD-1 Itsm and ITIM in regulating interactions with SHP-2, ZAP-70 and Lck, and PD-1-mediated inhibitory function","volume":"122","author":"Chatterjee","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2023.110609_bib10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","article-title":"SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation","volume":"173","author":"Chemnitz","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2023.110609_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2023.110609_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vetimm.2023.110609_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234218","article-title":"PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade","volume":"15","author":"Ganbaatar","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2023.110609_bib14","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/iid3.510","article-title":"Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1\/programmed death-ligand 1 blockade","volume":"9","author":"Ganbaatar","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.vetimm.2023.110609_bib15","doi-asserted-by":"crossref","unstructured":"Garon, E.B., Rizvi, N.A., Hui, R., Leighl, N., Balmanoukian, A.S., Eder, J.P., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., Carcereny, E., Ahn, M.J., Felip, E., Lee, J.S., Hellmann, M.D., Hamid, O., Goldman, J.W., Soria, J.C., Dolled-Filhart, M., Rutledge, R.Z., Zhang, J., Lunceford, J.K., Rangwala, R., Lubiniecki, G.M., Roach, C., Emancipator, K., Gandhi, L., 2015. Pembrolizumab for the treatment of non\u2013small-cell lung cancer. N. Engl. J. Med. 372, 2018\u20132028. https:\/\/doi.org\/10.1056\/nejmoa1501824.","DOI":"10.1056\/NEJMoa1501824"},{"key":"10.1016\/j.vetimm.2023.110609_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/22221751.2022.2037397","article-title":"Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant","volume":"11","author":"Gaudreault","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.vetimm.2023.110609_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/iid3.173","article-title":"Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-\u03b3 production via PD-1\/PD-L1 blockade in bovine mycoplasmosis","volume":"5","author":"Goto","year":"2017","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.vetimm.2023.110609_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fvets.2020.00012","article-title":"Upregulation of PD-L1 expression by prostaglandin E2 and the enhancement of IFN-\u03b3 by anti-PD-L1 antibody combined with a COX-2 inhibitor in Mycoplasma bovis infection","volume":"7","author":"Goto","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.vetimm.2023.110609_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell. Res."},{"key":"10.1016\/j.vetimm.2023.110609_bib20","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/cncr.24429","article-title":"Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with Sipuleucel-T in advanced prostate cancer","volume":"115","author":"Higano","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.vetimm.2023.110609_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1297-9716-42-103","article-title":"Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade","volume":"42","author":"Ikebuchi","year":"2011","journal-title":"Vet. Res."},{"key":"10.1016\/j.vetimm.2023.110609_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1297-9716-44-59","article-title":"Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro","volume":"44","author":"Ikebuchi","year":"2013","journal-title":"Vet. Res."},{"key":"10.1016\/j.vetimm.2023.110609_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/imm.12243","article-title":"Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes","volume":"142","author":"Ikebuchi","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.vetimm.2023.110609_bib24","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1158\/1078-0432.CCR-13-0458","article-title":"Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells","volume":"19","author":"John","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2023.110609_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vetimm.2023.110609_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4049\/jimmunol.181.1.116","article-title":"Programmed death (PD)-1:PD-ligand 1\/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis","volume":"181","author":"Jurado","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2023.110609_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vetimm.2023.110609_bib28","doi-asserted-by":"crossref","unstructured":"Lin, D.Y., Tanaka, Y., Iwasaki, M., Gittis, A.G., Su, H.P., Mikami, B., Okazaki, T., Honjo, T., Minato, N., Garboczi, D.N., 2008. The PD-1\/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc. Natl. Acad. Sci. U. S. A. 105, 3011\u20133016. https:\/\/doi.org\/10.1073\/pnas.0712278105.","DOI":"10.1073\/pnas.0712278105"},{"key":"10.1016\/j.vetimm.2023.110609_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098415","article-title":"Expression of PD-L1 on canine tumor cells and enhancement of IFN-\u03b3 production from tumor-infiltrating cells by PD-L1 blockade","volume":"9","author":"Maekawa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2023.110609_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157176","article-title":"Immunohistochemical analysis of PD-L1 expression in canine malignant cancers and PD-1 expression on lymphocytes in canine oral melanoma","volume":"11","author":"Maekawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2023.110609_bib31","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1038\/s41598-017-09444-2","article-title":"A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma","volume":"7","author":"Maekawa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vetimm.2023.110609_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41698-021-00147-6","article-title":"PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma","volume":"5","author":"Maekawa","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.vetimm.2023.110609_bib33","doi-asserted-by":"crossref","first-page":"11536","DOI":"10.1128\/JVI.00485-08","article-title":"Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism","volume":"82","author":"Muthumani","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2023.110609_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01430-22","article-title":"Combined immune checkpoint blockade enhances antiviral immunity against bovine leukemia virus","volume":"97","author":"Nakamura","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2023.110609_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174916","article-title":"In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection","volume":"12","author":"Nishimori","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2023.110609_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.vetimm.2023.110609_bib37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2009.00292.x","article-title":"Neuropathogenesis of naturally occurring encephalitis caused by Listeria monocytogenes in ruminants","volume":"20","author":"Oevermann","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.vetimm.2023.110609_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1297-9716-43-45","article-title":"Increased bovine Tim-3 and its ligand expressions during bovine leukemia virus infection","volume":"43","author":"Okagawa","year":"2012","journal-title":"Vet. Res."},{"key":"10.1016\/j.vetimm.2023.110609_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/IAI.01014-15","article-title":"Bovine immunoinhibitory receptors contribute to suppression of Mycobacterium avium subsp. paratuberculosis-specific T-cell responses","volume":"84","author":"Okagawa","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vetimm.2023.110609_bib40","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1128\/IAI.00278-16","article-title":"Cooperation of PD-1 and LAG-3 contributes to T-cell exhaustion in Anaplasma marginale-infected cattle","volume":"84","author":"Okagawa","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vetimm.2023.110609_bib41","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fimmu.2017.00650","article-title":"Anti-bovine programmed death-1 rat-bovine chimeric antibody for immunotherapy of bovine leukemia virus infection in cattle","volume":"8","author":"Okagawa","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vetimm.2023.110609_bib42","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.vetimm.2023.110609_bib43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection","volume":"45","author":"Penna","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.vetimm.2023.110609_bib44","first-page":"316","article-title":"Experimental infection of sheep with bovine leukemia virus (BLV): minimum dose of BLV-FLK cells and cell-free BLV and neutralization activity of natural antibodies","volume":"51","author":"Porta","year":"2019","journal-title":"Rev. Argent. Microbiol."},{"key":"10.1016\/j.vetimm.2023.110609_bib45","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vetimm.2023.110609_bib46","doi-asserted-by":"crossref","first-page":"e00910","DOI":"10.1128\/IAI.00910-17","article-title":"Prostaglandin E2 induction suppresses the Th1 immune responses in cattle with Johne\u2019s disease","volume":"86","author":"Sajiki","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vetimm.2023.110609_bib47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.1900342","article-title":"Prostaglandin E2-induced immune exhaustion and enhancement of antiviral effects by anti-PD-L1 antibody combined with COX-2 inhibitor in bovine leukemia virus infection","volume":"203","author":"Sajiki","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2023.110609_bib48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4049\/immunohorizons.2000089","article-title":"Enhanced immunotherapeutic efficacy of anti\u2013PD-L1 antibody in combination with an EP4 antagonist","volume":"4","author":"Sajiki","year":"2020","journal-title":"Immunohorizons"},{"key":"10.1016\/j.vetimm.2023.110609_bib49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1590\/1413-785220162405161949","article-title":"Sheep as an experimental model for biomaterial implant evaluation","volume":"24","author":"Sartoretto","year":"2016","journal-title":"Acta Ortop. Bras."},{"key":"10.1016\/j.vetimm.2023.110609_bib50","doi-asserted-by":"crossref","unstructured":"Selenko-Gebauer, N., Majdic, O., Szekeres, A., H\u00f6fler, G., Guthann, E., Korth\u00e4uer, U., Zlabinger, G., Steinberger, P., Pickl, W.F., Stockinger, H., Knapp, W., St\u00f6ckl, J., 2003. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170, 3637\u20133644.","DOI":"10.4049\/jimmunol.170.7.3637"},{"key":"10.1016\/j.vetimm.2023.110609_bib51","doi-asserted-by":"crossref","first-page":"L12","DOI":"10.1152\/ajplung.00169.2010","article-title":"Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs","volume":"300","author":"Sow","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.vetimm.2023.110609_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1465-9921-12-106","article-title":"Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs","volume":"12","author":"Sow","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.vetimm.2023.110609_bib53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/08820139.2011.631657","article-title":"Ontogeny of the immune response in the ovine lung","volume":"41","author":"Sow","year":"2012","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.vetimm.2023.110609_bib54","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: molecular evolutionary genetics analysis version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.vetimm.2023.110609_bib55","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.vetimm.2023.110609_bib56","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.vetimm.2023.110609_bib57","doi-asserted-by":"crossref","first-page":"158S","DOI":"10.1016\/j.jse.2007.03.002","article-title":"Experiences with sheep as an animal model for shoulder surgery: strengths and shortcomings","volume":"16","author":"Turner","year":"2007","journal-title":"J. Shoulder Elb. Surg."},{"key":"10.1016\/j.vetimm.2023.110609_bib58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in vivo by PD-1 blockade","volume":"458","author":"Velu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2023.110609_bib59","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12917-019-2082-7","article-title":"Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-\u03b3 production","volume":"15","author":"Watari","year":"2019","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.vetimm.2023.110609_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.vetimm.2023.110609_bib61","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1200\/JCO.2015.66.1389","article-title":"Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma","volume":"35","author":"Weber","year":"2017","journal-title":"J. Clin. Oncol."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242723000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242723000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:29:40Z","timestamp":1759044580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242723000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":61,"alternative-id":["S0165242723000636"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2023.110609","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization of immunoinhibitory factors PD-1\/PD-L1 in sheep","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2023.110609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110609"}}